Firefly Neuroscience AIFF
NASDAQ AIFF
$1.13 +0.03 (+2.73%)
At close: Sep 4, 2026 · 4:00 PM EDT

Firefly Neuroscience (AIFF) Amortization of Deferred Charges (2025)

Firefly Neuroscience (AIFF) posted Amortization of Deferred Charges of $126000.0 for Q1 2025.

Analysis

Firefly Neuroscience (AIFF) Amortization of Deferred Charges (2025) Analysis & Trends

Firefly Neuroscience has reported Amortization of Deferred Charges for 1 years, with the latest figure at $126000.0 in Q1 2025.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $126000.0 in Q1 2025; TTM through Dec 2025 was $126000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $126000.0, changed N/A from the prior year.
  • Amortization of Deferred Charges was $126000.0 for Q1 2025 at Firefly Neuroscience.
  • The five-year high for Amortization of Deferred Charges was $126000.0 in Q1 2025, with the low at $126000.0 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 31.10 Bn 29.22 Bn 2.18 Bn
2 Lantheus Holdings 6.59 Bn 6.00 Bn 241.86 Mn
3 Heartflow 4.24 Bn 3.87 Bn 53.19 Mn
4 Neogen 2.58 Bn 2.39 Bn 107.80 Mn
5 Butterfly Network 1.75 Bn 1.62 Bn 23.29 Mn
6 QuidelOrtho 954.15 Mn 830.75 Mn -
7 Ceribell 944.88 Mn 815.62 Mn 25.94 Mn
8 Anbio Biotechnology 941.05 Mn 929.15 Mn -
9 Varex Imaging 780.16 Mn 694.86 Mn 76.70 Mn
10 Firefly Neuroscience 23.25 Mn 14.03 Mn 253,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 126,000.00